Search Within

Andrew Pei-En Lin

Formats
  1. Meeting Abstract (33)
  2. Journal Article (15)
  3. Guidelines (1)
  4. Research Letter (1)
Groups
  1. Clinical Pharmacy Specialists (50)
  2. Department of Medicine (49)
  3. Hematologic Malignancies, Division of (47)
  4. Center for Hematologic Malignancies (45)
  5. Bone Marrow Transplant (43)
  6. Survivorship Research (36)

More Groups

People
  1. Sergio Giralt (34)
  2. Miguel-Angel Perales (24)
  3. Sean Devlin (24)
  4. Gunjan Shah (22)
  5. Valkal Bhatt (22)
  6. Anthony Proli II (19)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (8)
  5. 2021 (1)
  6. 2020 (6)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (16)
  2. Blood (11)
  3. Transplantation and Cellular Therapy (6)
  4. Bone Marrow Transplantation (4)
  5. Blood Advances (3)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. American Society of Hematology (14)
  3. Nature Publishing Group (4)
  4. Wiley Blackwell (2)
  5. Adis International Ltd (1)
  6. Elsevier Science BV (1)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Letermovir in hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry
    Journal Article

    Schofield, R. C.; Landau, H. J.; Giralt, S. A.; Shah, G. L.; Scordo, M.; Lin, A.; Zanutto, E.; Ramanathan, L. V.; Pessin, M. S.; Carlow, D. C.
    Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences (2019)

    Fulltext@MSK | Save
  • Dysgeusia is associated with higher melphalan pharmacokinetic levels and results in poorer caloric intake and worse symptom burden after autologous stem cell transplantation for multiple myeloma
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Preston, E. V.; Rodriguez, N.; Lin, A.; Maloy, M.; Mastrogiacomo, B.; Carlow, D.; Schofield, R.; Knezevic, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Outcomes in elderly hematopoietic stem cell transplant patients receiving tacrolimus graft-versus-host disease prophylaxis
    Meeting Abstract

    Griffin, M.; Zheng, J.; Lin, A.; Maloy, M.; Glezerman, I.; Jakubowski, A. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Impact of omitting post-transplant mini-methotrexate doses in allogeneic hematopoietic cell transplantation: A single-center retrospective study
    Meeting Abstract

    Lin, A.; Hilden, P.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; Tamari, R.; Ponce, D. M.; Giralt, S. A.; Gyurkocza, B.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Beyer, K.; Proli, A. J.; Zheng, J. T.; Bhatt, V.; Lin, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Perales, M. A.; Castro-Malaspina, H.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with relapsed multiple myeloma undergoing CD34-selected allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Lin, A.; Drill, E.; Proli, A. J.; Beyer, K.; Bhatt, V.; Devlin, S. M.; Koehne, G.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Outpatient foscarnet administration incorporating home infusions is feasible greatly enhancing the care of hematopoietic stem cell transplant recipients
    Meeting Abstract

    Beyer, K.; Abboud, M.; Hambright, K.; Lin, A.; Proli, A. J.; Bhatt, V.; Castillo, C.; Ponce, D. M.; Barker, J. N.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save